What is the appropriate management and follow-up for an older adult patient with a recent fall, negative X-ray (X-ray) for fractures, and prescribed Flexeril (cyclobenzaprine) 10mg orally three times a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Fall Management with Negative X-Ray and Flexeril Prescription

For an older adult with a fall and negative initial X-rays, prescribe Flexeril 5 mg three times daily (not 10 mg) for a maximum of 2-3 weeks, schedule follow-up within 2-3 days to reassess for occult fracture, and immediately initiate osteoporosis evaluation with bisphosphonate therapy and calcium/vitamin D supplementation. 1, 2

Immediate Medication Management

Flexeril Dosing Correction

  • Start with 5 mg three times daily, not 10 mg three times daily, as the lower dose provides equivalent efficacy with significantly less sedation in older adults 1, 3
  • The FDA label explicitly states that elderly patients should be initiated at 5 mg and titrated slowly upward due to increased plasma concentrations and higher risk of CNS adverse events including falls, hallucinations, and confusion 1
  • Limit treatment duration to 2-3 weeks maximum, as use beyond this period is not recommended and efficacy declines after the first week 1, 4
  • Critical pitfall: The 10 mg three times daily dose substantially increases fall risk in elderly patients through sedation, which could precipitate another fall and subsequent fracture 1

Medication Safety Monitoring

  • Warn the patient that Flexeril impairs mental and physical abilities required for driving or operating machinery, especially when combined with alcohol or other CNS depressants 1
  • Monitor for anticholinergic effects including urinary retention, confusion, and dry mouth, which are more pronounced in elderly patients 1
  • Screen for drug interactions, particularly with SSRIs, SNRIs, TCAs, tramadol, or MAO inhibitors due to serotonin syndrome risk 1

Critical Follow-Up Timeline

Early Re-Evaluation (2-3 Days)

  • Schedule follow-up within 2-3 days to assess for occult fracture, as initial X-rays can miss up to 10% of hip fractures, particularly basicervical femoral neck fractures 2
  • If pain worsens or fails to improve, obtain MRI of the hip immediately, as demonstrated in the AAOS case where a basicervical fracture was only detected on MRI after initially negative radiographs 2
  • Assess functional status including baseline mobility, independence in ADLs, and living situation to guide ongoing management 5

One-Week Assessment

  • Re-evaluate pain control and functional improvement, as cyclobenzaprine efficacy is greatest in the first 4 days and declines after the first week 4
  • If no improvement by 7 days, discontinue Flexeril and consider alternative diagnoses or imaging 1, 4

Mandatory Osteoporosis Evaluation and Treatment

Immediate Pharmacological Intervention

  • Start oral bisphosphonates (alendronate or risedronate) immediately for any patient over 50 with a fall, as this represents a fragility event requiring fracture prevention 2, 6, 7
  • Bisphosphonates reduce vertebral fractures by 47-48%, non-vertebral fractures by 26-53%, and hip fractures by 40-51% 6, 7
  • All patients must receive calcium 1000-1200 mg daily plus vitamin D 800 IU daily, which reduces non-vertebral fractures by 15-20% and falls by 20% 2, 6, 7
  • Critical pitfall: Do not use calcium or vitamin D alone without bisphosphonates, as monotherapy has no demonstrated fracture reduction effect 6, 7

Systematic Follow-Up Protocol

  • Implement a five-step Fracture Liaison Service approach: identify the patient, invite for fracture risk evaluation, perform differential diagnosis, initiate therapy, and establish systematic follow-up 7
  • Monitor regularly for medication tolerance and adherence, as long-term adherence to bisphosphonates is poor without structured follow-up 2
  • Continue bisphosphonates for 3-5 years initially, with reassessment for continuation based on ongoing fracture risk 6

Fall Prevention and Rehabilitation

Immediate Non-Pharmacological Interventions

  • Initiate home safety assessment, medication review (particularly sedating medications), and vision/hearing assessment to reduce fall risk 5
  • Begin early physical training and muscle strengthening as tolerated, with individual functional goals identified before developing the rehabilitation plan 2
  • Prescribe weight-bearing exercises, resistance training, and balance exercises to improve bone density and reduce fall risk 5

Lifestyle Modifications

  • Counsel on smoking cessation and alcohol limitation, as both negatively affect bone density, bone quality, and fall risk 2
  • Ensure adequate nutrition to support bone health and muscle strength 5

Multidisciplinary Coordination

Required Specialist Involvement

  • Coordinate care between primary care, orthopedics, and rheumatology/endocrinology for comprehensive osteoporosis management 5
  • Consider orthogeriatric comanagement for frail elderly patients with multiple comorbidities and polypharmacy 2

Patient Education

  • Educate about the burden of osteoporosis, risk factors for fractures, and importance of medication adherence 2
  • Discuss the 20% risk of subsequent fracture within one year after an initial fragility event 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cyclobenzaprine and back pain: a meta-analysis.

Archives of internal medicine, 2001

Guideline

Initial Management of Closed Complete Middle-Distal Third Humerus Fracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pharmacological Interventions to Reduce Fracture Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Post-Reduction Management and Prevention of Subsequent Fractures in Colles Fracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.